Clinical Trials Browser

Phase 2 × Interventional × Atorvastatin × Clear all

NCT04915183 2026-05-22

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Phase 2 Recruiting

Breast Neoplasms, Cardiotoxicity

NCT02958852 2025-09-10

ABC-SE

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

NCT02943590 2025-05-15

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

Phase 2 Completed

300 enrolled 13 charts

Heart Failure

NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT03872388 2024-10-02

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Phase 2 Terminated

6 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05675787 2024-07-11

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT06327451 2024-03-25

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT03358017 2023-10-19

YAPPETIZER

Phase 2 Completed

Triple Negative Breast Neoplasms

NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Phase 2 Completed

14 enrolled 9 charts

Erectile Dysfunction

NCT03186404 2022-02-08

SPARE-HF

Phase 2 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

NCT01759836 2022-01-25

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT01988571 2022-01-04

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Phase 2 Completed

279 enrolled 26 charts

Breast Neoplasms, Lymphoma

NCT02497638 2021-04-19

LIGAND

Phase 2 Withdrawn

Prostatic Neoplasms

NCT03275376 2021-03-16

Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

Phase 2 Terminated

Overall Survival

NCT01527045 2020-01-02

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Phase 2 Completed

47 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT02674204 2019-05-15

STOP

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

NCT01220973 2018-06-08

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Phase 2 Completed

27 enrolled 6 charts

Prostatic Neoplasms

NCT01821404 2018-05-07

ESTO1

Phase 2 Completed

Inflammation, Prostatic Neoplasms

NCT01491958 2018-01-23

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Phase 2 Completed

40 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02022293 2017-12-04

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

Phase 2 Suspended

Nasopharyngeal Carcinoma, Carotid Stenosis

NCT00185731 2017-12-02

Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Phase 2 Completed

25 enrolled 11 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT02029573 2017-08-18

ART

Phase 2 Completed

Glioblastoma

NCT01525407 2017-08-17

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Phase 2 Completed

83 enrolled 16 charts

Neoplasms

NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Phase 2 Completed

85 enrolled 10 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT01733953 2016-12-14

Statin Therapy in Young Adult Survivors of Childhood Cancer

Phase 2 Completed

27 enrolled 11 charts

LymphoidOther hematologic neoplasm

Cardiovascular Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02416427 2015-04-15

TRINACRIA

Phase 2 Unknown

Breast Neoplasms

NCT00529542 2014-09-25

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

Phase 2 Completed

20 enrolled 20 charts

Polycystic Ovary Syndrome

NCT00490698 2013-03-18

Zoledronate With Atorvastatin in Renal Cell Carcinoma

Phase 2 Completed

11 enrolled 5 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00816244 2012-04-13

Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00914017 2010-02-11

Statins and Breast Cancer Biomarkers

Phase 2 Unknown

Breast Neoplasms